BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares shot up 1.3% during trading on Monday . The stock traded as high as $1.52 and last traded at $1.52. 25,791 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.50.
BioRestorative Therapies Price Performance
The firm’s fifty day simple moving average is $1.60 and its 200 day simple moving average is $1.74. The company has a market capitalization of $2.49 billion, a price-to-earnings ratio of -1.42 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- Where Do I Find 52-Week Highs and Lows?
- Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Datadog Is the AI Infrastructure Firm to Watch Out For
- 3 Stocks to Consider Buying in October
- 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
